ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 165 filers reported holding ACORDA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $1,000 | -50.0% | 212 | 0.0% | 0.00% | – |
Q2 2019 | $2,000 | -99.7% | 212 | -99.0% | 0.00% | -100.0% |
Q3 2014 | $718,000 | +0.6% | 21,181 | 0.0% | 0.00% | -50.0% |
Q2 2014 | $714,000 | -11.1% | 21,181 | 0.0% | 0.00% | -20.0% |
Q1 2014 | $803,000 | +29.9% | 21,181 | 0.0% | 0.01% | +25.0% |
Q4 2013 | $618,000 | -14.6% | 21,181 | 0.0% | 0.00% | -33.3% |
Q3 2013 | $724,000 | – | 21,181 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PFM Health Sciences, LP | 1,526,174 | $1,423,000 | 0.12% |
GSA CAPITAL PARTNERS LLP | 250,271 | $233,000 | 0.06% |
Spark Investment Management LLC | 110,300 | $102,000 | 0.05% |
SALZHAUER MICHAEL | 30,000 | $28,000 | 0.05% |
HAP Trading, LLC | 260,800 | $532,000 | 0.04% |
Point72 Asset Management, L.P. | 1,589,600 | $1,482,000 | 0.01% |
DLD Asset Management, LP | 208,400 | $196,000 | 0.01% |
ACADIAN ASSET MANAGEMENT LLC | 1,893,678 | $1,765,000 | 0.01% |
EVERENCE CAPITAL MANAGEMENT INC | 65,680 | $61,000 | 0.01% |
Benin Management CORP | 11,714 | $11,000 | 0.01% |